Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death

PACE - Pacing and Clinical Electrophysiology

Volumn 32, Issue SUPPL. 2, 2009, Pages

  Berul, Charles I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Defibrillation ICD; Pediatrics

Indexed keywords

BRUGADA SYNDROME; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILDHOOD DISEASE; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CONVULSIVE THERAPY; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART RIGHT VENTRICLE DYSPLASIA; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; PRIMARY PREVENTION; REVIEW; SECONDARY PREVENTION; SHORT QT SYNDROME; SUDDEN DEATH; TREATMENT INDICATION;

ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; INFANT; INFANT, NEWBORN; YOUNG ADULT;

EID: 68249161332     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02388.x     Document Type: Review

References (39)

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335 : 1933 1940.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999 341 : 1882 1890.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al. Sudden Cardiac Death in Heart Failure Trial. N Engl J Med 2005 352 : 225 237.
4. Josephson ME, Wellens HJ. Implantable cardioverter-defibrillators and sudden cardiac death. Circulation 2004 109 : 2685 2691.
5. Mirowski M, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980 303 : 322 324.
6. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997 337 : 1576 1583.
7. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001 22 : 1374 1450.
8. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002 106 : 2145 2161. (Pubitemid 35192824)
9. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996 77 : 524 526.
10. Link MS, Hill SL, Cliff DL, Swygman CA, Foote CB, Homoud MK, Wang PJ, et al. Comparison of frequency of complications of implantable cardioverter- defibrillators in children versus adults. Am J Cardiol 1999 83 : 263 266.
11. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004 15 : 72 76.
12. Gradaus R, Wollmann C, Köbe J, Hammel D, Kotthoff S, Block M, Breithardt G, et al. Potential benefit from ICD therapy in children and young adolescents. Heart 2004 90 : 328 329.
13. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents. Pacing Clin Electrophysiol 2004 27 : 924 932.
14. Ten Harkel AD, Blom NA, Reimer AG, Tukkie R, Sreeram N, Bink-Boelkens MT. Implantable cardioverter defibrillator in children in the Netherlands. Eur J Pediatr 2005 164 : 436 441.
15. Eicken A, Kolb C, Lange S, Brodherr-Heberlein S, Zrenner B, Schreiber C, Hess J. Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol 2006 107 : 30 35.
16. Berul CI, Van Hare G, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, et al. Results of a multicenter retrospective implantable cardioverter defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008 51 : 1685 1691.
17. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003 14 : 337 341.
18. Monnig G, Kobe J, Loher A, Eckardt L, Wedekind H, Scheld HH, Haverkamp W, et al. Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: A long-term follow-up. Heart Rhythm 2005 2 : 497 504.
19. Silka MJ, Kron J, Dunnigan A, Dick M 2nd. Sudden cardiac death and the use of ICDs in pediatric patients. The Pediatric Electrophysiology Society. Circulation 1993 87 : 800 807.
20. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J. Use of ICDs in congenital long QT syndrome. Am J Cardiol 1996 78 : 703 706.
21. Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, et al. The Jervell and Lange-Nielsen syndrome: Natural history, molecular basis, and clinical outcome. Circulation 2006 113 : 783 790.
22. Goldenberg I, Moss AJ, Zareba W, McNitt S, Robinson JL, Qi M, Towbin JA, et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol 2006 17 : 1161 1168.
23. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P. Idiopathic short QT interval: A new clinical syndrome? Cardiology 2000 94 : 99 102.
24. Schimpf R, Bauersfeld U, Gaita F, Wolpert C. Short QT syndrome: Successful prevention of sudden cardiac death in an adolescent by ICD treatment for primary prophylaxis. Heart Rhythm 2005 2 : 416 417.
25. Boriani G, Biffi M, Valzania C, Bronzetti G, Martignani C. Short QT syndrome and arrhythmogenic cardiac diseases in the young: The challenge of implantable cardioverter-defibrillator therapy for children. Eur Heart J 2006 27 : 2382 2384.
26. Stephenson EA, Berul CI. Electrophysiological interventions for inherited arrhythmia syndromes. Circulation 2007 116 : 1062 1080.
27. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995 91 : 1512 1519.
28. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992 20 : 1391 1396.
29. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, et al. Brugada syndrome: Report of the Second Consensus Conference. Circulation 2005 111 : 659 670. (Pubitemid 40216496)
30. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002 105 : 1342 1347. (Pubitemid 34260426)
31. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Haissaguerre M, Mansourati J, et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. Circulation 2006 114 : 2317 2324.
32. Dubin AM, Berul CI, Bevilacqua LM, Collins KK, Etheridge SP, Fenrich AL, Friedman RA, et al. Implantable cardioverter-defibrillators in pediatric and complex congenital heart disease patients awaiting heart transplant. J Card Fail 2003 9 : 375 379.
33. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000 342 : 365 373.
34. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, et al. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000 36 : 2212 2218.
35. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy. Circulation 2003 108 : 3084 3091.
36. Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2004 43 : 1843 1852.
37. Hauer RN, Aliot E, Block M, Capucci A, Luderitz B, Santini M, Vardas PE, for the European Society of Cardiology. Working Group on Arrhythmias and Working Group on Cardiac Pacing. Indications for implantable cardioverter defibrillator (ICD) therapy. Eur Heart J 2001 22 : 1074 1081.
38. Berul CI, Triedman JK, Forbess J, Bevilacqua LM, Alexander ME, Dahlby D, Gilkerson JO, et al. Minimally invasive cardioverter defibrillator implantation for children. Pacing Clin Electrophysiol 2001 24 : 1789 1794.
39. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, et al. A multicenter experience with novel ICD configurations in pediatric and congenital heart disease. J Cardiovasc Electrophysiol 2006 17 : 41 46.